A View of the Public Ophthalmology Market & Exit Trends

The IPO market in ophthalmology may have cooled off last year, but that only mirrored what’s happened in healthcare overall. In this video from OIS@AAO 2016, JP Morgan’s Joe Gilliam explains why indicators bode well for IPO activity in medtech and ophthalmology.

Presentation Slides:

Presentation Audio:


Joseph Gilliam

Joe Gilliam

Mr. Gilliam has more than 17 years’ experience that includes strategic advisory services, private and public equity and debt financings. Prior to J.P. Morgan, Mr. Gilliam was at The Beacon Group, a strategic advisory and private equity firm.

View Full Profile